[April 11, 2014]

Research and Markets: Cardiovascular Diseases Therapeutics in Major Developed Markets 2013-2019 - US, UK, Germany, France, Italy, Spain, Japan and Canada

Research and Markets (http://www.researchandmarkets.com/research/ch54lp/cardiovascular) has announced the addition of the "Cardiovascular Diseases Therapeutics in Major Developed Markets 2013-2019 " report to their offering.

Cardiovascular Diseases Therapeutics in Major Developed Markets 2013-2019 provides insights into three cardiovascular therapeutic indications in the top eight markets of the US, the UK, Germany, France, Italy, Spain, Japan and Canada.

The value of the CVD market in the US is the highest of the countries covered in this report, amounting to an estimated $6.1 billion in 2012 and is expected to grow at a Compound Annual Growth Rate (CAGR) of 4.7% over the forecast period to reach $8.49 billion in 2019. The market for all geographis (US, UK, Germany, France, Spain, Italy, Canada and Japan) totaled $13.7 billion in 2012 and is expected to grow at a CAGR of 4.1% to reach $18.2 billion in 2019.

The report provides an in-depth analysis of the cardiovascular therapeutic indications, namely heart failure, myocardial infarction (MI), acute coronary syndrome (ACS (News - Alert)). The report provides an estimation of market size for 2012, along with market forecast until 2019. It also covers disease epidemiology, treatment algorithms, treatment patterns, in-depth analysis of the pipeline, and deal analysis for these three cardiovascular indications.

Scope

• Disease overview and treatment usage patterns
• Market size and forecast for heart failure, Myocardial Infarction (MI) and Acute Coronary Syndrome (ACS)
• Geographic coverage includes the top eight markets (the US, the UK, Germany, France, Italy, Spain, Japan and Canada) from 2012 to 2019
• Major marketed products for the indications types covered
• In-depth pipeline analysis for heart failure, MI and ACS
• Key drivers and restraints that have had and are expected to have a significant impact upon the market
• Key licensing and co-development agreements in the cardiovascular market

Key Topics Covered:

1. Tables & Figures
2. Introduction
3. Therapeutic Landscape
4. Marketed Products
   
5. Pipeline Analysis
6. Cardiovascular Diseases Global Market to 2019, Market Forecast
7. Deals and Strategic Consolidations
8. Appendix

For more information visit http://www.researchandmarkets.com/research/ch54lp/cardiovascular

[ Back To TMCnet.com's Homepage ]